• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚肝炎病毒学中心首届病毒性肝炎研究公共小组讨论-科学传播的经验教训。

The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research-Lessons in Scientific Community Outreach.

机构信息

Australian Centre for Hepatitis Virology, Melbourne, VIC 3000, Australia.

Centre for Infectious Diseases and Microbiology, Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.

出版信息

Viruses. 2021 Sep 15;13(9):1838. doi: 10.3390/v13091838.

DOI:10.3390/v13091838
PMID:34578419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8472947/
Abstract

Viral hepatitis remains one of the most significant health issues globally, directly responsible for over 1 million deaths each year and affecting almost 300 million people around the world. Scientific research in recent decades has brought about improvements in the lives of people living with chronic viral hepatitis. On the 29 July 2021, the Australian Centre for Hepatitis Virology (ACHV) for the first time held a public educational forum for the general public. The main aim of this event was to inform the affected community about the importance of scientific research and give an overview of upcoming developments in the field. Here, we provide a detailed report of the panel discussion (including its organisation, execution, and lessons learned to incorporate into future events) and provide strategies that can be used by other scientific societies to hold similar events in their own communities.

摘要

病毒性肝炎仍然是全球最重要的健康问题之一,每年直接导致超过 100 万人死亡,影响全球近 3 亿人。近几十年来的科学研究为慢性病毒性肝炎患者的生活带来了改善。2021 年 7 月 29 日,澳大利亚肝炎病毒学中心 (ACHV) 首次为公众举办了一个公共教育论坛。此次活动的主要目的是向受影响的社区宣传科学研究的重要性,并概述该领域即将出现的新发展。在这里,我们详细报告了小组讨论(包括其组织、执行情况以及为今后的活动吸取的经验教训),并提供了其他科学学会可以在其所在社区举办类似活动的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e41/8472947/bb3b73b093be/viruses-13-01838-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e41/8472947/72b17d16692b/viruses-13-01838-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e41/8472947/bb3b73b093be/viruses-13-01838-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e41/8472947/72b17d16692b/viruses-13-01838-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e41/8472947/bb3b73b093be/viruses-13-01838-g002.jpg

相似文献

1
The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research-Lessons in Scientific Community Outreach.澳大利亚肝炎病毒学中心首届病毒性肝炎研究公共小组讨论-科学传播的经验教训。
Viruses. 2021 Sep 15;13(9):1838. doi: 10.3390/v13091838.
2
Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis.连接基础科学和临床研究:EASL 病毒性肝炎转化研究专题会议。
J Hepatol. 2014 Sep;61(3):696-705. doi: 10.1016/j.jhep.2014.05.016. Epub 2014 May 15.
3
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
4
Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.在澳大利亚悉尼,通过社区外展活动,让注射毒品的人参与丙型肝炎病毒检测和预防。
Drug Alcohol Rev. 2019 Feb;38(2):177-184. doi: 10.1111/dar.12895. Epub 2019 Jan 16.
5
Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop.乙型肝炎和丁型肝炎领域的主要开放性问题 - 首届国际新兴乙型肝炎和丁型肝炎研究人员研讨会论文集。
Virology. 2024 Jul;595:110089. doi: 10.1016/j.virol.2024.110089. Epub 2024 Apr 16.
6
Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.输血传播人类免疫缺陷病毒、乙型肝炎病毒、丙型肝炎病毒和人类嗜T淋巴细胞病毒的残余风险。
Intern Med J. 2005 Oct;35(10):592-8. doi: 10.1111/j.1445-5994.2005.00926.x.
7
NIH consensus development statement on management of hepatitis B.美国国立卫生研究院关于乙型肝炎管理的共识发展声明。
NIH Consens State Sci Statements. 2008;25(2):1-29.
8
Virology of hepatitis B and C viruses and antiviral targets.乙型和丙型肝炎病毒的病毒学及抗病毒靶点
J Hepatol. 2006;44(1 Suppl):S10-3. doi: 10.1016/j.jhep.2005.11.005. Epub 2005 Nov 21.
9
Prevalence of HBV and HCV markers among patients attending the Saint Camille Medical Centre in Ouagadougou.瓦加杜古圣卡米尔医疗中心就诊患者中乙肝病毒和丙肝病毒标志物的流行情况。
Pak J Biol Sci. 2012 May 15;15(10):484-9. doi: 10.3923/pjbs.2012.484.489.
10
Immunology of hepatitis B virus and hepatitis C virus infection.乙型肝炎病毒和丙型肝炎病毒感染的免疫学
Nat Rev Immunol. 2005 Mar;5(3):215-29. doi: 10.1038/nri1573.

本文引用的文献

1
The Nobel Prize for discovery of HCV is a call to end hepatitis.因发现丙型肝炎病毒而获得的诺贝尔奖是终结肝炎的号角。
Lancet. 2020 Nov 28;396(10264):1733. doi: 10.1016/S0140-6736(20)32282-0. Epub 2020 Oct 29.
2
The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure.慢性乙型肝炎的真实体验:更全面地了解其影响,以及我们为何需要治愈它。
Viruses. 2020 May 7;12(5):515. doi: 10.3390/v12050515.
3
Modeling Progress Toward Elimination of Hepatitis B in Australia.建模实现澳大利亚消除乙型肝炎的进展。
Hepatology. 2020 Apr;71(4):1170-1181. doi: 10.1002/hep.30899. Epub 2019 Oct 14.
4
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.在澳大利亚新南威尔士州直接作用抗病毒治疗时代,丙型肝炎病毒相关肝病负担下降。
J Hepatol. 2019 Aug;71(2):281-288. doi: 10.1016/j.jhep.2019.04.014. Epub 2019 May 10.
5
Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012.乙肝和丙肝患者的死亡率趋势:基于人群的关联研究,1993-2012 年。
BMC Infect Dis. 2018 May 9;18(1):215. doi: 10.1186/s12879-018-3110-0.
6
Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.实现丙型肝炎病毒消除目标需要卫生系统干预措施来加强护理链。
Int J Drug Policy. 2017 Sep;47:107-116. doi: 10.1016/j.drugpo.2017.07.006. Epub 2017 Aug 7.
7
Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.核酸聚合物可预防鸭乙型肝炎病毒在体内感染。
Antimicrob Agents Chemother. 2013 Nov;57(11):5299-306. doi: 10.1128/AAC.01005-13. Epub 2013 Aug 12.
8
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.丙型肝炎病毒亚基因组RNA在肝癌细胞系中的复制
Science. 1999 Jul 2;285(5424):110-3. doi: 10.1126/science.285.5424.110.
9
Protective efficacy of DNA vaccines against duck hepatitis B virus infection.DNA疫苗对鸭乙型肝炎病毒感染的保护效力。
J Virol. 1998 Jan;72(1):84-94. doi: 10.1128/JVI.72.1.84-94.1998.
10
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.通过接种转录RNA进行肝内丙型肝炎传播。
Science. 1997 Jul 25;277(5325):570-4. doi: 10.1126/science.277.5325.570.